DIMENSIONAL FUND ADVISORS LP
Position in CATX — Perspective Therapeutics, Inc.
CIK 354204
AUSTIN, TX
Position in CATX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,876,903
+$1,625,122 QoQ
Shares Held
450,097
+391.6% QoQ
Ownership
0.395%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,538,254,948 across 64 Medical Devices names. CATX ranks #47 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
8,852,797 | $908,916,665 | |
| 2 | MDT |
Medtronic plc
|
7,516,150 | $651,274,396 | |
| 3 | SYK |
Stryker Corp
|
1,242,500 | $408,273,073 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
5,399,439 | $384,332,066 | |
| 5 | BSX |
Boston Scientific Corp
|
6,097,777 | $382,635,505 | |
| 6 | BIO |
Bio-Rad Laboratories, Inc.
|
1,089,323 | $303,648,784 | |
| 7 | EW |
Edwards Lifesciences Corp
|
3,636,881 | $291,241,428 | |
| 8 | STE |
STERIS plc
|
1,113,845 | $246,304,542 |
All Filings in CATX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,876,903 | 450,097 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $251,781 | 91,557 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||